J. Alimonti

发表

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™

J. Strong, X. Qiu, G. Wong, 2014, Nature.

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

Yan Li, Jin Hyun Kim, Michael G. Katze, 2007, Nature.

Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS.

J. Alimonti, T. Ball, K. Fowke, 2003, The Journal of general virology.

Protective Immunodominant Zaire Ebolavirus Glycoprotein Epitope in Mice

X. Qiu, L. Fernando, J. Alimonti, 2011 .

1 Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of

Sherif, J. Alimonti, Steven J M Jones, 2010 .

Pathogenesis and Immune Response of Crimean-Congo Hemorrhagic Fever Virus in a STAT-1 Knockout Mouse Model

J. Alimonti, Steven J M Jones, W. Shieh, 2010, Journal of Virology.

Monoclonal Antibodies Combined with Adenovirus-Vectored Interferon Significantly Extend the Treatment Window in Ebola Virus-Infected Guinea Pigs

X. Qiu, G. Wong, L. Fernando, 2013, Journal of Virology.

EBOLA Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates

X. Qiu, G. Wong, J. Alimonti, 2012 .

Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies.

X. Qiu, L. Fernando, J. Alimonti, 2011, Clinical immunology.

Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever.

L. Fernando, J. Alimonti, Steven J M Jones, 2007, The Journal of infectious diseases.

BNIP3 and Genetic Control of Necrosis-Like Cell Death through the Mitochondrial Permeability Transition Pore

J. Alimonti, R. Hakem, S. Israels, 2000, Molecular and Cellular Biology.

Surrogate Antigen Processing Mediated by TAP-dependent Antigenic Peptide Secretion

W. Jefferies, J. Alimonti, R. Gabathuler, 1998, The Journal of cell biology.

Immune Response to Marburg Virus Angola Infection in Nonhuman Primates.

X. Qiu, L. Fernando, J. Alimonti, 2015, The Journal of infectious diseases.

Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory

J. Strong, X. Qiu, G. Wong, 2014, Scientific Reports.

IL‐7Rα expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation

J. Alimonti, C. Wachihi, F. Plummer, 2006, European journal of immunology.

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

W. J. Ramsey, T. Monath, R. Davey, 2017, The New England journal of medicine.

Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial

W. J. Ramsey, T. Monath, J. Alimonti, 2017, Canadian Medical Association Journal.

VSVΔG/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection.

X. Qiu, L. Fernando, J. Alimonti, 2015, Viral immunology.

Using the TAP Component of the Antigen-Processing Machinery as a Molecular Adjuvant

W. Jefferies, J. Alimonti, G. Basha, 2005, PLoS pathogens.

Zika virus crosses an in vitro human blood brain barrier model

J. Alimonti, M. Bani‐Yaghoub, W. Conlan, 2018, Fluids and Barriers of the CNS.

Granzyme B Induces Bid-Mediated Cytochrome C Release and Mitochondrial Permeability Transition

J. Alimonti, Lianfa Shi, A. Greenberg, 2001, TheScientificWorldJournal.

Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses

X. Qiu, L. Fernando, J. Alimonti, 2009, PloS one.

Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates

X. Qiu, G. Wong, J. Alimonti, 2012, Science Translational Medicine.

Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents

X. Qiu, G. Wong, J. Audet, 2014, Vaccine.

Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb

X. Qiu, G. Wong, J. Audet, 2013, Scientific Reports.

Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies

X. Qiu, G. Wong, J. Audet, 2012, Science Translational Medicine.

Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection

X. Qiu, J. Audet, L. Fernando, 2012, PLoS neglected tropical diseases.

Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.

R. Davey, J. Alimonti, G. Kobinger, 2015, JAMA.

mAbs and Ad-Vectored IFN-α Therapy Rescue Ebola-Infected Nonhuman Primates When Administered After the Detection of Viremia and Symptoms

X. Qiu, G. Wong, J. Audet, 2013, Science Translational Medicine.

A common CD4 gene variant is associated with an increased risk of HIV-1 infection in Kenyan female commercial sex workers.

Allison M. Land, J. Alimonti, T. Ball, 2009, The Journal of infectious diseases.

In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics.

J. Alimonti, H. Ebihara, H. Feldmann, 2007, The Journal of infectious diseases.

In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein.

G. Neumann, Y. Kawaoka, J. Alimonti, 2007, The Journal of infectious diseases.

Mechanisms of CD 4 + T lymphocyte cell death in human immunodeficiency virus infection and AIDS

J. Alimonti, T. Ball, K. Fowke, 2003 .

Characterization of CD8+ T‐cell responses in HIV‐1‐exposed seronegative commercial sex workers from Nairobi, Kenya

R. Kaul, J. Alimonti, C. Wachihi, 2006, Immunology and cell biology.

Zika virus crosses an in vitro human blood brain barrier model

J. Alimonti, M. Bani‐Yaghoub, W. Conlan, 2018, Fluids and Barriers of the CNS.

CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women.

J. Alimonti, C. Wachihi, F. Plummer, 2005, The Journal of infectious diseases.

In Vitro Techniques

B. Peter, I. Mills, M. Hetzer, 2006 .

Purification of human interleukin-2 using the cellulose-binding domain of a prokaryotic cellulase.

J. Greenwood, J. Alimonti, D. Kilburn, 1995, Bioseparation (Dordrecht).

Granzyme B Induces BID-mediated Cytochrome c Release and Mitochondrial Permeability Transition*

J. Alimonti, Lianfa Shi, A. Greenberg, 2001, The Journal of Biological Chemistry.

Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies

X. Qiu, G. Wong, J. Audet, 2012, Science Translational Medicine.

mAbs and Ad-Vectored IFN-α Therapy Rescue Ebola-Infected Nonhuman Primates When Administered After the Detection of Viremia and Symptoms

X. Qiu, G. Wong, J. Audet, 2013, Science Translational Medicine.